Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience


Pricing
Go Premium Now
Login
Best Dividend Stocks
Ex-Dividend Dates
High Yield Stocks
Strategies
Tools
Articles
Premium
Advisors
Guaranteed Income

Pfizer logo in blue

News

Pfizer Inc. Beats Q4 Estimates (PFE)

Shauna O'Brien Jan 27, 2015


Before Tuesday’s opening bell, Pfizer Inc. (PFE ) released its fourth quarter financial results, reporting a drop in profit.


PFE’s Earnings in Brief


  • The company reported net income of $1.228 billion, or 19 cents per share, compared to $2.568 billion, or 39 cents per share, last year.
  • Excluding special items, earnings were 54 cents per share – above analysts’ view of 53 cents per share.
  • Revenue came in at $13.12 billion, up from $13.56 billion last year. Analysts expected to see revenue of $12.90 billion.
  • Looking forward, the company expects to see FY2015 revenue between $44.5 billion and $46.5 billion, and adjusted earnings between $2.00 and $2.10 per share. On average, analysts expect to see $47.56 billion in revenue and EPS of $2.18.


PFE’s Dividend


Pfizer will pay its next 28 cent quarterly dividend on March 3. The stock will go ex-dividend on February 4.


Stock Performance


Shares of PFE were down 30 cents, or 0.91%, during pre-market trading Tuesday.

PFE Dividend Snapshot

As of market close on January 26, 2015


PFE dividend yield annual payout payout ratio dividend growth


Click here to see the complete history of PFE dividends.


The Bottom Line


Pfizer (PFE ) is recommended at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Popular Articles